HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.

AbstractBACKGROUND AND STUDY AIMS:
Local failure after chemoradiotherapy (CRT) remains a major problem for patients with esophageal squamous cell carcinoma (ESCC). The aim of this study was to clarify the long-term results of salvage photodynamic therapy (PDT) for local failure.
PATIENTS AND METHODS:
Patients were treated with CRT, consisting of more than 50 Gy irradiation and concurrent chemotherapy. The indications for salvage PDT were as follows: 1) absence of lymph-node or distant metastasis after CRT; 2) failure lesion limited to T2; 3) refusal by patient to undergo salvage esophagectomy; 4) written informed consent. PDT was performed using an excimer dye laser at 48 and 72 hours after administration of Photofrin.
RESULTS:
A total of 37 consecutive patients underwent salvage PDT. The baseline stage before CRT was as follows: T1/T2/T3/T4 in 3/4/24/6 and N0/1 in 13/24 patients, respectively. Prior to PDT, 20 patients had a uT1 lesion, and 17 had a uT2 lesion; 24 patients had histologically proven local failure. A complete response was achieved in 22 patients (59.5%) following PDT. Esophageal fistulae, stenosis, and phototoxicity occurred in 4 (10.8%), 20 (54.1%), and 2 (5.4%) patients, respectively. Over a median follow-up period of 55 months, the 5-year progression-free (PFS) and overall survival rates of 37 patients following PDT were 20.7% and 36.1%, respectively. The 5-year PFS and overall survival of 24 patients with proven local failure were 17.6% and 34.6%, respectively.
CONCLUSION:
Salvage PDT is a curative treatment option for patients with local failure after CRT for ESCC.
AuthorsT Yano, M Muto, K Minashi, M Onozawa, K Nihei, S Ishikura, K Kaneko, A Ohtsu
JournalEndoscopy (Endoscopy) Vol. 43 Issue 8 Pg. 657-63 (Aug 2011) ISSN: 1438-8812 [Electronic] Germany
PMID21623555 (Publication Type: Journal Article)
Copyright© Georg Thieme Verlag KG Stuttgart · New York.
Chemical References
  • Photosensitizing Agents
  • Dihematoporphyrin Ether
Topics
  • Aged
  • Carcinoma, Squamous Cell (pathology, therapy)
  • Chemoradiotherapy
  • Dihematoporphyrin Ether (therapeutic use)
  • Disease-Free Survival
  • Esophageal Neoplasms (pathology, therapy)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Lasers, Dye (therapeutic use)
  • Male
  • Middle Aged
  • Photochemotherapy
  • Photosensitizing Agents (therapeutic use)
  • Retrospective Studies
  • Salvage Therapy
  • Time Factors
  • Treatment Failure
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: